Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8525941 | Biomedicine & Pharmacotherapy | 2018 | 19 Pages |
Abstract
Chronic hepatitis is a general designation class of diseases, which results in different degrees of liver necrosis and inflammatory reaction, followed by liver fibrosis, may eventually develop into cirrhosis. However, the molecular pathogenesis of chronic hepatitis is too complex to elucidate. Herbal medicines, featured with multiple targets and compounds, have long displayed therapeutic effect in treating chronic hepatitis, though their molecular mechanisms of contribution remain indistinct. This research utilized the network pharmacology to confirm the molecular pathogenesis of chronic hepatitis through providing a comprehensive analysis of active chemicals, drug targets and pathways' interaction of Sinisan formula for treating chronic hepatitis. The outcomes showed that 80 active ingredients of Sinisan formula interacting with 91 therapeutic proteins were authenticated. Sinisan formula potentially participates in immune modulation, anti-inflammatory and antiviral activities, even has regulating effects on lipid metabolism. These mechanisms directly or indirectly are involved in curing chronic hepatitis by an interaction way. The network pharmacology based analysis demonstrated that Sinisan has multi-scale curative activity in regulating chronic hepatitis related biological processes, which provides a new potential way for modern medicine in the treatment of chronic diseases.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Zhiming Shu, He Wang, Mohamed Shahen, Zihu Guo, Jia Shu, Tiantian Wu, Xiaoyu Bian, Akhtar Hussain Shar, Mayada Ragab Farag, Mahmoud Alagawany, Chaobin Liu,